Used as a key intermediate in the synthesis of pharmaceuticals and bioactive compounds, particularly in Suzuki-Miyaura cross-coupling reactions to form carbon-carbon bonds. Its ortho-substituted acetamido group enhances stability and directs regioselectivity during coupling, making it valuable in drug development. Commonly employed in the preparation of protease inhibitors and other therapeutic agents where precise molecular architecture is critical. Also utilized in the design of boron-containing compounds for potential applications in medical imaging and targeted therapies.